Théa Open Innovation is a sister company of Laboratoires Théa. Its aim is to identify, evaluate and support the most innovative developments in eye care, by implementing license agreements and/or capital investments with partners. Théa Open Innovation brings:
- its expertise in ophthalmology development and the necessary funding partners need to achieve proof of concept in humans
- ability to drive clinical development, registration, pricing, market access and commercialization.
Laboratoires Théa is a pharmaceutical company 100% dedicated to Ophthalmology, independent, owned and run by the Chibret Family. The Chibret have been devoted to ophthalmology for 5 generations over 150 years with a presence in 75 countries, more than 31 direct subsidiaries, and a turnover close to 865 M€. Théa has the biggest sales force (Medical Reps) in Europe.
At Théa Open Innovation, we believe that the future requires innovation, diversification, partnership and efficiency.
photo Zhiguo He